Skip to main content

Table 1 The 22 case reports or case series

From: Mixed neuroendocrine-non-neuroendocrine carcinoma of gallbladder: case report

Number

Author [ref.]

Age/sex

Neuroendocrine component

Epithelial component

1

Acosta et al. [6]

55/F

NEC, LCNEC

Intestinal-type adenocarcinoma

2

Al-Brahim and Albannai [7]

45/M

NEC, LCNEC

Adenocarcinoma

3

Harada et al. [8]

70/F

NEC, small cell carcinoma

Well-differentiated adenocarcinoma

4

Harada et al. [8]

70/F

NEC, LCNEC

Well-differentiated papillary adenocarcinoma

5

Harada et al. [8]

70/F

NET G2, atypical carcinoid

Well-differentiated adenocarcinoma

6

Harada et al. [8]

60/F

NEC, small cell carcinoma

Well-differentiated papillary adenocarcinoma

7

Harada et al. [8]

50/F

NEC, LCNEC

Well-differentiated adenocarcinoma

8

Iype et al. [9]

85/M

NEC, LCNEC

Adenocarcinoma

9

Jung et al. [10]

54/F

NEC, LCNEC

Adenosquamous carcinoma

10

Kamboj et al. [11]

65/F

Unknown

Unknown

11

Kim et al. [12]

Unknown/M

Unknown

Unknown

12

Kim et al. [12]

Unknown/M

Unknown

Unknown

13

Lin et al. [13]

43/F

NEC, small cell carcinoma

Adenocarcinoma

14

Liu et al. [14]

63/F

NEC, LCNEC

Moderately differentiated adenocarcinoma

15

Meguro et al. [15]

54/F

NEC, LCNEC

Poorly differentiated biliary type adenocarcinoma

16

Mondolfi et al. [16]

48/F

NEC, LCNEC

Papillary adenocarcinoma

17

Noske and Pahl [17]

81/F

Poorly differentiated LCNEC

Moderately differentiated adenocarcinoma

18

Oshiro et al. [18]

55/F

NEC, small cell carcinoma, LCNEC

Papillary adenocarcinoma, tubular adenocarcinoma

19

Sato et al. [19]

68/F

NEC, LCNEC

Well-differentiated tubular adenocarcinoma

20

Shimiziu et al. [20]

58/M

NEC, small cell carcinoma

Well-differentiated tubular adenocarcinoma

21

Shintaku et al. [21]

80/M

NET G2

Tubular adenocarcinoma, squamous cell carcinoma, osteosarcoma

22

Song et al. [22]

55/F

NEC, small cell carcinoma

Adenocarcinoma

  1. NEC neuroendocrine carcinoma; LCNEC large cell neuroendocrine carcinoma; NET G2 neuroendocrine tumor, grade 2; F female; M male